qsymia glp 1 With all the media coverage for GLP1 agonists, it's easy to assume that they are the only weight loss medications available. While they are on average the most potent option, there are How GLP-1 medications are transforming

2013 May;125(9-10):239-43

Proudly Made in USA, GMP Compliant, FDA Registered Facility

This article shows that unimolecular GLP1/GIP co-agonism corrects obesity and glucose intolerance in obese rodents and non-human primates

Sustainable success in the Obesity Medicine market will not just be about assets or portfolios of assets, but also active influence across the full patient weight loss and weight maintenance journey, which will mean new partnerships between emergent actors (digital health platforms, patients themselves)

So, its safe to use these other options without any extra precautions when taking a GLP-1 agonist